CD4 and myeloid sarcoma: However, unlike the CD4+ T cells from healthy controls that secreted comparable amounts of IL37 both upon resting conditions and upon stimulation with anti-CD3 + antiCD28, this stimulation of the CD4+ T cells from MS patients determined a significant (p < 0.01) reduction in IL37 secretion (Figure 1A).